CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-06 | Butler John P. CEO and President | Option exercise | +350,000 | $0.63 | $221K | 3,718,564 |
| 2026-08-06 | Butler John P. CEO and President | Option exercise · Stock Option (Right to buy) | −350,000 | 525,000 | ||
| 2026-06-29 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −56,019 | $1.11 | $62K | 616,616 |
| 2026-06-17 | FRIESON RON Director | Grant or award | +35,700 | 165,200 | ||
| 2026-06-17 | FRIESON RON Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2026-06-17 | Wolf Myles Director | Grant or award | +35,700 | 169,081 | ||
| 2026-06-17 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2026-06-17 | Smith Cynthia Director | Grant or award | +35,700 | 196,633 | ||
| 2026-06-17 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2026-06-17 | ADAMS ADRIAN Director | Grant or award | +35,700 | 236,200 | ||
| 2026-06-17 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2026-06-17 | ROGERS MICHAEL W Director | Grant or award | +35,700 | 197,429 | ||
| 2026-06-17 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2026-06-17 | ZUMWALT LEANNE M Director | Grant or award | +35,700 | 145,100 | ||
| 2026-06-17 | ZUMWALT LEANNE M Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2026-04-01 | Vickers Philip J. Director | Grant or award · Stock Option (Right to buy) | +214,400 | 214,400 | ||
| 2026-03-04 | Butler John P. CEO and President | Purchase | +69,270 | $1.25 | $87K | 3,367,064 |
| 2026-02-02 | Rucci Carolyn M. SVP, Chief Legal Officer | Sale 10b5-1 | −16,846 | $1.39 | $23K | 641,304 |
| 2026-02-02 | Rucci Carolyn M. SVP, Chief Legal Officer | Sale 10b5-1 | −25,382 | $1.39 | $35K | 615,922 |
| 2026-02-02 | Rucci Carolyn M. SVP, Chief Legal Officer | Sale 10b5-1 | −27,544 | $1.39 | $38K | 588,378 |
Page 1 of 21 · 405 trades